Navigation Links
Study finds women with triple negative breast cancer and BRCA mutations have lower risk of recurrence
Date:9/29/2010

HOUSTON - Patients with triple negative breast cancer that also have mutations in the BRCA gene appear to have a lower risk of recurrence, compared to those with the same disease without the deleterious genetic mutation, according to researchers at The University of Texas MD Anderson Cancer Center.

The findings may offer a direction for study of personalized therapy in this select group of triple negative breast cancer patients, as well as highlight the unique need for genetic testing in a patient population. Ana M. Gonzalez-Angulo, M.D., associate professor in MD Anderson's Departments of Breast Medical Oncology and Systems Biology presented the findings in advance of the 2010 Breast Cancer Symposium.

"There is data on the number of breast cancer patients with BRCA mutations, as well as those that have triple negative disease. However, there is no understanding of the incidence of BRCA1 and 2 mutations in unselected patients with triple negative breast cancer," said Gonzalez-Angulo, the study's first and corresponding author. "Now, there are new drugs that appear to be more effective in treating triple negative breast cancer and BRCA status may be an important way of selecting patients that may respond to these therapies."

Triple negative disease - breast cancer that is estrogen, progesterone and HER2-neu receptor negative - accounts for about 15 percent of all breast cancers. Currently, it's an area of much research focus in the breast cancer community because: it lacks effective targets effective for anti-cancer therapies; chemotherapy is only effective in about 40 percent of patients; and in those that do relapse, the disease is highly resistant and patients die quickly.

PARP inhibitors, a class of drugs of growing interest in cancer research, have shown promise in both patients with BRCA and triple negative disease. PARPs appear to be more effective in patients with BRCA mutations, as both PARP enzymes and protei
'/>"/>

Contact: Laura Sussman
lsussman@mdanderson.org
713-745-2457
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. UT MD Anderson study finds women treated for breast cancer while pregnant have improved survival
2. Anti-Inflammatory Helps Treat Bacterial Meningitis: Study
3. UTHealth researcher receives grant for Alzheimers study
4. Dirty hands, dirty mouths: U-M study finds a need to clean the body part that lies
5. Study Finds Home Dialysis as Good as Hemodialysis at Centers
6. C-Reactive Protein Levels Vary By Race: Study
7. TGen/Mayo Clinic/Arizona Cancer Center study finds gene associated with aggressive skin cancer
8. Pet allergies worsen hay fever symptoms, Queens study finds
9. Wider statin use could be cost-effective preventive measure, Stanford study finds
10. New Tool Helps Predict Stroke Patients Risk of Death in Hospital: Study
11. VCU study: Researchers discover a drug combination that shrinks tumors in vivo
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study finds women with triple negative breast cancer and BRCA mutations have lower risk of recurrence
(Date:5/28/2015)... The partners of Urgent Care of Westchester and ... Almendral as their chief provider for advanced beauty treatments. ... opened facility’s plan to offer all of Westchester County ... Almendral is a board certified physician who is trained ... techniques. Her areas of expertise include Botox, Dermal Fillers, ...
(Date:5/28/2015)... On Sunday, June 21, 2015, Colorado residents will ... honor the strength, passion and endurance of those facing ... of this sunrise-to-sunset event symbolizes the challenging journey of ... raise funds and awareness to advance the care, support ... are encouraged to create their own experience as they ...
(Date:5/28/2015)... Dr. Jenyons’ Medical Weight Loss & Rejuvenation ... looking to undergo its advanced Micro-Needling skin rejuvenating procedure. ... able to get a single Micro-Needling treatment with plasma, ... three-treatment package, which costs $1,800, the clinic will add ... Juanita Jenyons, M.D., says Dr. Jenyons’ Medical Weight Loss ...
(Date:5/28/2015)... 28, 2015 Medelis, Inc., a specialty ... the company in the role of president. , “ Bill ... the CRO industry,” said Larry Flanagan, Medelis’ CEO and co-founder. ... through our next phase of growth.” , Taaffe joined ... from nine employees to over 4,500 employees, achieving 12 consecutive ...
(Date:5/28/2015)... May 28, 2015 Altima Technologies, ... Device Library for documenting and diagramming data center ... for the following product lines: , Manufacturer ... 5500, Chatsworth Products N-Series TeraFrame Cabinet, Middle Atlantic ... Eclipse, Fore Systems ForeRunner, Marantz America MM Series, ...
Breaking Medicine News(10 mins):Health News:Bella Diosa Med Spa Welcomes Botox Specialist to Yonkers Community 2Health News:Dr. Jenyons’ Medical Weight Loss & Rejuvenation Center Now Offering Skin Treatment Specials 2Health News:Dr. Jenyons’ Medical Weight Loss & Rejuvenation Center Now Offering Skin Treatment Specials 3Health News:Bill Taaffe, Former President and CEO of ICON Clinical Research-US, Joins Medelis, a Specialty Oncology CRO, in the Role of President 2Health News:NetZoom™ Visio® Stencil Library Updates for EMC, Cisco, and Chatsworth Products 2
... Loosening of Welfare Reform Rules Alter Longstanding System of ... Current versions of both the House and Senate health ... fail to prevent millions of illegal aliens from accessing ... Immigration Reform (FAIR). And in a radical change from ...
... protein implicated in rare form of bowel disorder, researchers ... with painful, chronic bowel conditions such as Crohn,s disease ... from new research. , Scientists say they,ve spotted a ... of colitis, and the finding might have implications for ...
... Inc. (Nasdaq: SGMO ) today reported third quarter 2009 ... ended September 30, 2009, Sangamo reported a consolidated net loss ... consolidated net loss of $6.3 million, or $0.15 per share, ... 2009, the company had cash, cash equivalents, marketable securities and ...
... ), the largest provider of deathcare products and services in North America, today reported results for ... end of this press release. The table below summarizes our key financial results: , , ... ... (In millions, except for September 30, ...
... drug makers, consumers, patients , WEDNESDAY, Nov. 4 (HealthDay ... designed to reduce preventable injuries and deaths caused by ... will focus on preventable injuries and deaths caused by ... attempts at self- harm," Dr. Janet Woodcock, director of ...
... Allergy and Infectious Diseases (NIAID), part of the National ... two programs that support research to better understand the ... including those that may be introduced into a community ... to the Cooperative Centers for Translational Research on Human ...
Cached Medicine News:Health News:Health Care Reform Legislation Becomes Vehicle for Reshaping Immigration Policy 2Health News:Health Care Reform Legislation Becomes Vehicle for Reshaping Immigration Policy 3Health News:Gene Discovery Gives Clues to Crohn's Disease, Colitis 2Health News:Gene Discovery Gives Clues to Crohn's Disease, Colitis 3Health News:Sangamo BioSciences Reports Third Quarter 2009 Financial Results 2Health News:Sangamo BioSciences Reports Third Quarter 2009 Financial Results 3Health News:Sangamo BioSciences Reports Third Quarter 2009 Financial Results 4Health News:Sangamo BioSciences Reports Third Quarter 2009 Financial Results 5Health News:Sangamo BioSciences Reports Third Quarter 2009 Financial Results 6Health News:Sangamo BioSciences Reports Third Quarter 2009 Financial Results 7Health News:Sangamo BioSciences Reports Third Quarter 2009 Financial Results 8Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 2Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 3Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 4Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 5Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 6Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 7Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 8Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 9Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 10Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 11Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 12Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 13Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 14Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 15Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 16Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 17Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 18Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 19Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 20Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 21Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 22Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 23Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 24Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 25
(Date:5/28/2015)... May 28, 2015 Research ... addition of the "United States Medical Adhesives ... their offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ... the United States is ... Medical device manufacturers across the US ...
(Date:5/28/2015)... May 28, 2015 Isis Pharmaceuticals, Inc. (NASDAQ: ... Therapeutics WebcastWhen: , Thursday, June 4 at 1:00 p.m. ... , Live on the Internet.  Simply log onto our ... during the live event, a replay of the webcast ... www.isispharm.com . ABOUT ISIS PHARMACEUTICALS, INC. Isis ...
(Date:5/28/2015)... Md. , May 28, 2015 ... it will be a supporting organization of the ... and sterilization in 2016. Johnson & ... series of high-profile superbug infections in endoscopes. J&J ... health issues between 1976 and 2003 on advances ...
Breaking Medicine Technology:United States Medical Adhesives Market Forecast and Opportunities, 2020 - New Medical Innovations with 3M, Henkel Adhesive Research, Ethicon and Cyberbond Dominating 2United States Medical Adhesives Market Forecast and Opportunities, 2020 - New Medical Innovations with 3M, Henkel Adhesive Research, Ethicon and Cyberbond Dominating 3Webcast Alert: Akcea Therapeutics Conference Call 2Webcast Alert: Akcea Therapeutics Conference Call 3PDA Announces Support for the Johnson & Johnson Kilmer Conference 2
... a clinical-stage biopharmaceutical company focused on the development of ... other inflammatory diseases, announced today that CEO Martin Driscoll ... during the annual BIO International Convention.  Mr. Driscoll,s presentation ... Walter E. Washington Convention Center in Washington, DC on ...
... June 22, 2011 Amended 13D for RepliGen ... Ronald L. Chez, a private investor. Mr. Ronald ... a private investor. RepliGen Corporation is a biopharmaceutical company ... drugs that deliver the benefits of protein therapies in the fields ...
Cached Medicine Technology:Asmacure Ltee to Present at the 2011 BIO Business Forum During the Annual BIO International Convention 2
Indications For Usage: ,Pediatric (recommended tidal volume 70-250ml), single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intend...
Indications For Usage: ,Adult (recommended tidal volume >150ml), single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to...
... The Portex® Thermovent® T helps provide protection ... It is small and extremely lightweight making it ... adults. With a high rate of heat and ... secretion retention., ,All HMEs and filters have ...
... helps provide protection to the exposed airway of ... lightweight making it ideal for active young children ... of heat and moisture recovery, it ensures patient ... and filters have ISO standard tapered ends to ...
Medicine Products: